And how did you conduct your study and what did you find in your study, Dr. Baru?

So the preview experience program was basically a way for individuals to get real world experience with it outside of the setting of a trial, which was a phase three pivotal trial.

16 practices were selected based on movement disorders practices, based on their experience with botulinum toxins.

A total of 234 patients were enrolled, up to three cycles.

Not everybody got all the way to three cycles, but three cycles.

And of course, the main goal was to enroll patients that were having the issue of wearing off.

Approximately about 88% of individuals were botulinum toxin experienced, 12% were naive.

Knowing what you know, what are the logistics you would employ for a new patient in your own practice?